It is worth noting that GSTA1, NFE2L2, MAPT, ABCC1, APEX1, and POLK were highly expressed in T2D patients, compared to NonT2D (Figure S3, all p < 0.05). This evidence concerns the gene APEX1 and type 2 diabetes mellitus.